[1]
Krismeikesari Krismeikesari, “Comparative Efficacy and Safety of Finerenone, Eplerenone, and Spironolactone on Cardiorenal Outcomes in Type 2 Diabetes with Chronic Kidney Disease: A Systematic Review and Network Meta-Analysis”, OAIJMR, vol. 6, no. 1, pp. 1-20, Nov. 2025.